TCRX - TScan Therapeutics to Participate in Upcoming Investor Conferences | Benzinga
WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (NASDAQ:TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that management will participate in the following upcoming investor conferences:
- Morgan Stanley 21st Annual Global Healthcare Conference; the fireside chat will be held at the Sheraton New York on Tuesday, September 12th at 4:55 p.m. ET
- H.C. Wainwright 25th Annual Global Investment Conference; the presentation will be held ...